NUS team develops man-made molecule that can ‘kill’ skin cancer cells
Professor Carlos Ibanez says the use of the molecule to activate the “death receptor” of melanoma skin cancer cells presents an option for a new treatment method for the remaining 45 per cent of melanoma skin cancer patients for whom current treatment fails. Photo: NUS Yong Loo Lin School Of Medicine.
Read the full article HERE.
At the end of September each year, science journalists all over the world make their forecasts for the upcoming announcement of the Nobel Prizes that take place during the first week of October in Stockholm, Sweden. The week begins with the announcement of the winners of the Nobel Prize in Physiology or Medicine, awarded by the Karolinska Institute. It is followed by the Physics, Chemistry and Literature Prizes. As expected, this activity is all the more significant at Swedish newspapers and TV and radio stations, and this year of 2013 was no exception. Inger Atterstam, from the Svenska Dagbladet newspaper, is regarded as one of the most accredited science journalists in Sweden. Her 2013 forecast for the Physiology or Medicine Nobel Prize was vast and broad (to be on the safe side, presumably), and included scientists responsible for discoveries concerning the epidemiology of smoking, cochlea implants, treatments against malaria, rheumatoid arthritis, leukaemia and even Bill and Melinda Gates (!) (The nature of the discoveries made by the Gates couple which according to Ms. Atterstam deserved such a high honour was, however, not revealed).
